- Special Panel to Focus on Enhancing Innovation Necessary for the Approval of New National Emergency Medicine Countermeasure Products
RESEARCH TRIANGLE PARK, NC, February 23, 2010 - Chimerix, Inc., a biotechnology company developing orally-available…
> Read More
RESEARCH TRIANGLE PARK, NC, February 04, 2010 - Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced today that Gwendolyn Powell Painter, M.D., M.P.H., has joined the company as Chief Medical Officer.
Dr.…
> Read More